The risk of developing acute myeloid leukemia in patients with Ewing sarcoma and trend analysis: a SEER-based study
Patients treated for a primary ES have a significant risk of developing AML, among other second primary malignancies. Thus, we recommend screening for AML from 2 to 11 months after the diagnosis of ES for early detection and better management outcomes.
Authors
- A. Ellaithy (ORCID: https://orcid.org/0000-0002-6997-9689)
- Mahmoud Eleisawy
- Nahla Ali (ORCID: https://orcid.org/0000-0002-4459-3464)
- Mohamed Zahed
- Ekram Hasanin
- Bushra Al-Shaikh
- Alzahraa Faris Alesawy
- Sofian Zreigh
- Saifaleslam Jamal Elsahli
Institutions
- Suez Canal University (EG)
- Misurata University (LY)
- Sana'a University (YE)
- Benha University (EG)
- University of Tripoli (LY)
- John Radcliffe Hospital (GB)
- Oxford University Hospitals NHS Trust (GB)
- Ankara Yıldırım Beyazıt University (TR)
- Alexandria University (EG)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2025-12-03
- DOI
- https://doi.org/10.1097/ms9.0000000000004455
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00